← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2012Last known activity
Apr 14, 2023
Timeline
2010s
- Jun 1, 2010
Aslan Pharmaceuticals— Founded
Drugs by trial phase (11 distinct, 21 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (30)
- NCT05865041Study directorPhase 2Apr 14, 2023
- NCT05865041Lead sponsorPhase 2Apr 14, 2023
- NCT05694884Lead sponsorPhase 2Dec 21, 2022
- NCT05694884Study directorPhase 2Dec 21, 2022
- NCT05158023Study directorPhase 2Dec 31, 2021
- NCT05158023Lead sponsorPhase 2Dec 31, 2021
- NCT04090229Lead sponsorPhase 1Sep 30, 2019
- NCT03721263Lead sponsorPhase 1Oct 15, 2018
- NCT03451084Lead sponsorPhase 2Jan 5, 2018
- NCT03231176Lead sponsorPhase 2Dec 19, 2017
- NCT03368846Lead sponsorPhase 1Nov 23, 2017
- NCT03130790Lead sponsorPhase 2/Phase 3Sep 1, 2017
- NCT03093870Lead sponsorPhase 2/Phase 3Jul 4, 2017
- NCT03129074Lead sponsorPhase 2Jul 1, 2017
- NCT03082053Lead sponsorPhase 1Jan 31, 2017
Details
- Founded
- Singapore, SG Jun 1, 2010
- Last known activity
- Apr 14, 2023